Protein synthesis-dependent but Bcl-2-independent cytochrome C release in zinc depletion-induced neuronal apoptosis

J Neurosci Res. 2000 Sep 1;61(5):508-14. doi: 10.1002/1097-4547(20000901)61:5<508::AID-JNR5>3.0.CO;2-V.

Abstract

Previously, we reported that chelation of intracellular zinc with N, N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN)-induced macromolecule synthesis-dependent apoptosis of cultured cortical neurons. According to the current theory of apoptosis, release of mitochondrial cytochrome C into the cytosol is required for caspase activation. In the present study, we examined whether cytochrome C release is dependent on macromolecule synthesis. Exposure of cortical cultures to 2 microM TPEN for 24 hr induced apoptosis as previously described. Fluorescence immunocytochemical staining as well as immunoblots of cell extracts revealed the release of cytochrome C into the cytosol 18-20 hr after the exposure onset. The cytochrome C release was completely blocked by the addition of cycloheximide or actinomycin D. Addition of the caspase inhibitor zVAD-fmk did not attenuate the cytochrome C release, whereas it blocked TPEN-induced apoptosis. Because Bcl-2 has been shown to block cytochrome C release potently, we exposed human neuroblastoma cells (SH-SY5Y) to TPEN. Whereas Bcl-2 overexpression completely blocked both cytochrome C release and apoptosis induced by staurosporine, it attenuated neither induced by TPEN. The present results suggest that, in neurons, macromolecule synthesis inhibitors act upstream of cytochrome C release to block apoptosis and that, in addition to the classical Bcl-2 sensitive pathway, there may exist a Bcl-2-insensitive pathway for cytochrome C release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology*
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Cholinesterase Inhibitors / pharmacology
  • Cytochrome c Group / metabolism*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Ethylenediamines / pharmacology
  • Excitatory Amino Acid Agonists / pharmacology
  • Humans
  • Mice
  • Mitochondria / metabolism
  • N-Methylaspartate / pharmacology
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Protein Biosynthesis*
  • Protein Synthesis Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Transfection
  • Zinc / deficiency
  • Zinc / metabolism*

Substances

  • Cholinesterase Inhibitors
  • Cytochrome c Group
  • Enzyme Inhibitors
  • Ethylenediamines
  • Excitatory Amino Acid Agonists
  • Protein Synthesis Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • N-Methylaspartate
  • Zinc
  • N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine